AMS · XBRL financial data

American Shared Hospital Services financial statements, every quarter

The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (AMS's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	5,134	5,698*	5,216	7,056	6,999	9,069*	6,112	7,071	7,171	7,728*	7,084	8,430
Cost of revenue	3,032	2,882*	3,073	4,588	5,629	5,865*	5,170	5,441	5,585	6,822*	5,796	6,997
Gross profit	2,102	2,816*	2,143	2,468	1,370	3,204*	942	1,630	1,586	906*	1,288	1,433
Selling, general and administrative	1,735	1,760*	1,879	1,896	1,923	1,709*	1,808	1,746	1,538	1,986*	1,910	2,042
Operating income (loss)	90	407*	(85)	(1)	(889)	(1,830)*	(1,299)	(544)	(344)	(1,401)*	(924)	(910)
Interest expense	277	287*	349	385	336	429*	433	428	392	321*	302	301
Income tax expense (benefit)	60	338*	(44)	(31)	(169)	(51)*	(323)	(21)	48	(197)*	92	135
Net income (loss)	118	415*	119	3,602	(207)	(1,328)*	(625)	(280)	(17)	(631)*	(612)	(514)
Earnings per share, basic USD per share	0.02	0.06*	0.02	0.56	(0.03)	(0.20)*	(0.10)	(0.04)	0.00	(0.09)*	(0.09)	(0.07)
Earnings per share, diluted USD per share	0.02	0.07*	0.02	0.55	(0.03)	(0.19)*	(0.10)	(0.04)	0.00	(0.09)*	(0.09)	(0.07)
Weighted average shares, basic thousands of shares	6,366	6,423*	6,452	6,482	6,482	6,571*	6,572	6,582	6,632	6,677*	6,725	6,872
Weighted average shares, diluted thousands of shares	6,432	6,333*	6,576	6,583	6,482	7,168*	6,572	6,582	6,632	6,677*	6,725	6,872

Balance sheet

CSV

Fiscal quarters (AMS's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	14,537	13,690	12,792	14,236	13,827	11,025	11,241	11,081	5,095	3,462	4,973	6,511
Accounts receivable	3,986	4,343	6,429	8,606	8,635	11,610	8,737	9,576	11,806	10,521	10,566	8,323
Prepaid and other current assets	247	526	517	623	757	928	785	725	586	774	830	830
Total current assets	20,371	20,456	21,365	25,639	25,720	26,258	23,742	24,433	20,591	17,720	18,272	17,368
Right-of-use asset	94	57	36	631	986	1,015	3,064	3,011	3,750	3,648	3,610	3,571
Goodwill	1,265	1,265	1,265	1,265	1,265	1,265	1,265	1,265	1,265	1,265	1,265	1,265
Total assets	47,358	48,162	50,124	60,825	63,269	60,197	63,311	63,494	59,629	55,479	54,725	52,493
Accounts payable	346	315	267	859	1,786	1,562	1,231	806	1,107	607	1,081	582
Current portion of long-term debt	1,459	2,084	2,710	3,033	3,557	2,841	3,128	9,872	18,184	17,294	16,843	16,216
Total current liabilities	10,049	10,779	10,779	13,336	17,561	10,405	12,710	20,860	25,802	23,444	23,718	22,424
Long-term debt	10,454	11,041	12,892	12,050	10,818	17,341	16,798	9,222	0	0	—	—
Lease liability, non-current	11	0	—	1,615	1,500	1,500	3,667	3,640	4,304	4,229	4,187	4,145
Total liabilities	21,354	21,883	23,739	28,473	31,439	30,170	34,099	34,646	31,030	27,788	28,020	26,684
Retained earnings	3,214	3,629	3,748	7,350	7,143	5,815	5,190	4,910	4,893	4,262	3,650	3,136
Total stockholders' equity	22,111	22,624	22,841	26,542	26,423	25,183	24,647	24,481	24,565	24,034	23,523	23,111
Total liabilities and equity	47,358	48,162	50,124	60,825	63,269	60,197	63,311	63,494	59,629	55,479	54,725	52,493
Common shares outstanding (cover page) thousands of shares	≈6,300	6,330	≈6,330	≈6,360	6,420	6,450	≈6,450	≈6,510	6,543	6,602	6,625	≈6,650

≈ Rounded on cover: the filing states this count rounded, and it sits more than 1% off the weighted shares for the period.

Cash flows

CSV

Fiscal quarters (AMS's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	118	415*	119	3,602	(207)	(1,328)*	(625)	(280)	(17)	(631)*	(612)	(514)
Stock-based compensation	98*	98*	98	99*	88*	88*	89	114*	101*	100*	101	102*
Net cash from operating activities	3,564*	(3,060)*	(1,865)	1,286*	472*	274*	2,503	(372)*	1,671*	(704)*	2,149	2,236*
Purchases of property and equipment	3,615*	97*	1,183	1,216*	879*	4,660*	4,015	1,901*	3,702*	(1,984)*	41	58*
Net cash from investing activities	(3,615)*	(97)*	(1,183)	(853)*	(704)*	(4,365)*	(4,015)	(1,901)*	(3,702)*	1,984*	(41)	(58)*
Proceeds from long-term debt	—	year only	2,700	0*	0*	7,160*	0	0*	0*	0*	—	—
Repayments of long-term debt	429*	540*	164	539*	727*	1,304*	280	887*	934*	913*	472	640*
Net cash from financing activities	912*	2,310*	2,282	1,011*	(177)*	1,289*	1,728	2,113*	(3,955)*	(2,913)*	(597)	(640)*
Net change in cash	861*	(847)*	(766)	1,444*	(409)*	(2,802)*	216	(160)*	(5,986)*	(1,633)*	1,511	1,538*

Compare with peers

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
American Shared Hospital Services	6,511	8,430	2,236*	6.7M	—	Q2 FY26 10-QJun 30, 2026
CapForce	144	50,000	(618)*	12.4M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Ludwig Enterprises	18	not reported	(153)	167.2M	1.3 quarters	Q1 FY26 10-QMar 31, 2026
Biodesix	29,996	26,861	(1,562)*	10.6M	19.2 quarters	Q2 FY26 10-QJun 30, 2026
BioNexus Gene Lab	1,233	76	(422)*	2.9M	2.9 quarters	Q2 FY26 10-QJun 30, 2026
Aclarion	16,285	25	(2,657)*	2.9M	6.1 quarters	Q2 FY26 10-QJun 30, 2026
Advanced Biomed	386	year only	(583)*	1.7M	0.7 quarters	Q4 FY26 10-KJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.